Nutriband (NASDAQ: NTRB) has announced a temporary leadership change as CEO Gareth Sheridan steps down for three months to pursue a candidacy in the Irish Presidential election. During this period, Co-Founder and Chairman Serguei Melnik will assume the role of CEO, bringing his extensive experience in corporate strategy and capital markets to guide the company. This transition comes at a critical time as Nutriband progresses toward its 2026 NDA filing target for AVERSA Fentanyl, an abuse-deterrent opioid patch that has recently been granted a meeting request by the FDA.
The AVERSA Fentanyl patch represents a significant advancement in the fight against opioid abuse, designed to deter misuse and accidental exposure. With potential peak U.S. sales estimated between $80 million and $200 million, the technology is protected by patents in 46 countries, underscoring its global potential. Nutriband's leadership expresses confidence in the company's direction and the ongoing development of AVERSA Fentanyl, highlighting the importance of this innovation in addressing a critical public health issue.
For more details on Nutriband's announcement and the AVERSA Fentanyl patch, visit https://ibn.fm/YstUq. Additional information about Nutriband and its developments can be found in the company's newsroom at https://ibn.fm/NTRB.
